Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis

Por Dmitry S. Mikhaylenko, Ekaterina B. Kuznetsova, Viktoria V. Musatova, Irina V. Bure, Tatiana A. Deryagina, Ekaterina A. Alekseeva, Vadim V. Tarasov, Andrey A. Zamyatnin, Marina V. Nemtsova
Publicado em 2022-04-01

Analysis of miRNA Expression in Patients with Rheumatoid Arthritis during Olokizumab Treatment

Por Irina V. Bure, Dmitry S. Mikhaylenko, Ekaterina B. Kuznetsova, Ekaterina A. Alekseeva, Kristina I. Bondareva, Alexey I. Kalinkin, Alexander N. Lukashev, Vadim V. Tarasov, Andrey A. Zamyatnin, Marina V. Nemtsova
Publicado em 2020-10-01

Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response

Por Dmitry S. Mikhaylenko, Marina V. Nemtsova, Irina V. Bure, Ekaterina B. Kuznetsova, Ekaterina A. Alekseeva, Vadim V. Tarasov, Alexander N. Lukashev, Marina I. Beloukhova, Andrei A. Deviatkin, Andrey A. Zamyatnin
Publicado em 2020-07-01